Par Drugs and Chemicals Limited (NSE:PAR)
India · Delayed Price · Currency is INR 101.33
-1.15 (-1.12%)
Aug 21, 2026, 3:29 PM IST
Par Drugs and Chemicals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 131.09 | 133.58 | 145.01 | 113.34 | 92.13 |
Depreciation & Amortization | 37.03 | 36.47 | 34.36 | 32.33 | 32.81 |
Loss (Gain) From Sale of Assets | -0.06 | - | -0.08 | -1.43 | - |
Other Operating Activities | -27.73 | -10.14 | 3.17 | -5.84 | 5.46 |
Change in Accounts Receivable | 46.86 | -30 | 32.55 | 14.98 | -60.16 |
Change in Inventory | 7.33 | -19.29 | 12.02 | -6.66 | -17.16 |
Change in Accounts Payable | -26.98 | 55.35 | -27.35 | -25.7 | 39.44 |
Change in Other Net Operating Assets | -3.23 | -4.36 | 2.82 | 12.75 | -16.38 |
Operating Cash Flow | 164.32 | 161.6 | 202.49 | 133.77 | 76.15 |
Operating Cash Flow Growth | 1.68% | -20.19% | 51.37% | 75.66% | -36.99% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -19.62 | -12.27 | -60.8 | -76.34 | -32.02 |
Sale of Property, Plant & Equipment | 0.23 | - | 0.12 | 2 | - |
Investment in Securities | -20.66 | -250.58 | -0.02 | - | - |
Other Investing Activities | 18.38 | 10.48 | 2.32 | 0.96 | 1.84 |
Investing Cash Flow | -21.66 | -252.37 | -58.38 | -73.38 | -30.18 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Repaid | - | - | - | - | -32.4 |
Long-Term Debt Repaid | - | - | - | - | -43.9 |
Total Debt Repaid | - | - | - | - | -76.3 |
Net Debt Issued (Repaid) | - | - | - | - | -76.3 |
Common Dividends Paid | - | - | - | - | -15.3 |
Dividends Paid | - | - | - | - | -15.3 |
Other Financing Activities | - | - | - | -0.02 | -3.9 |
Financing Cash Flow | - | - | - | -0.02 | -95.5 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | 0 | 0 | - | -0.07 |
Net Cash Flow | 142.66 | -90.77 | 144.11 | 60.37 | -49.6 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 144.71 | 149.34 | 141.69 | 57.43 | 44.13 |
Free Cash Flow Growth | -3.10% | 5.40% | 146.69% | 30.15% | -37.28% |
Free Cash Flow Margin | 13.96% | 14.79% | 14.81% | 6.00% | 5.88% |
Free Cash Flow Per Share | 11.76 | 12.14 | 11.52 | 4.67 | 3.59 |
Levered Free Cash Flow | 120.31 | 121.5 | 121.43 | 42.52 | 34.24 |
Unlevered Free Cash Flow | 121.1 | 121.5 | 121.43 | 42.54 | 36.59 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | - | - | - | 0.02 | 3.7 |
Cash Income Tax Paid | 50.29 | 45.17 | 43.6 | 42.63 | 31.24 |
Change in Working Capital | 23.99 | 1.7 | 20.03 | -4.64 | -54.26 |